Achilles Therapeutics (ACHL)
1.13
-0.01 (-0.88%)
At close: Jan 28, 2025, 1:52 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -69.94M | -71.18M | -61.10M | -33.20M | -13.99M | -6.89K |
| Depreciation & Amortization | 4.71M | 3.69M | 3.29M | 772.00K | 302.00K | 173.00 |
| Stock-Based Compensation | 6.36M | 7.02M | 6.32M | 2.99M | 719.00K | 76.00 |
| Other Working Capital | 10.41M | -7.86M | -5.36M | -2.25M | -1.73M | -846 |
| Other Non-Cash Items | 7.03K | 6.88M | -18.00K | 1.18M | -9.00K | -114 |
| Deferred Income Tax | n/a | n/a | 159.00K | n/a | 14.00K | n/a |
| Change in Working Capital | 10.41M | -5.96M | -7.93M | 3.00M | -1.18M | -846 |
| Operating Cash Flow | -48.45M | -59.53M | -59.28M | -25.25M | -14.14M | -7.60K |
| Capital Expenditures | -1.10M | -7.51M | -7.63M | -11.85M | -942.00K | -258 |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -7.51M | -7.63M | n/a | n/a | n/a |
| Investing Cash Flow | -1.10M | -7.51M | -7.63M | -11.85M | -942.00K | -258 |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 160.75M | 113.70M | 93.23M | 13.51K |
| Financial Cash Flow | 9.00K | 1K | 160.75K | 113.70M | 93.62M | 13.51K |
| Net Cash Flow | -41.80M | -92.98M | 88.50M | 80.25M | 86.91M | 5.70K |
| Free Cash Flow | -49.55M | -67.05M | -66.92M | -37.10M | -15.08M | -7.86K |